Plinabulin, a microtubule destabilising agent, in non-small-cell lung cancer: lessons from the DUBLIN-3 trial

Lancet Respir Med. 2024 Oct;12(10):745-747. doi: 10.1016/S2213-2600(24)00191-7. Epub 2024 Sep 9.

Authors

Rafael Rosell¹, María González-Cao², Miguel Angel Molina-Vila³

Affiliations

¹ IOR, Hospital Quiron-Dexeus Barcelona, Spain. Electronic address: rrosell@oncorosell.com.
² IOR, Hospital Quiron-Dexeus Barcelona, Spain.
³ Pangaea Oncology, Hospital Quiron-Dexeus Barcelona, Spain.

PMID: 39265598
DOI: 10.1016/S2213-2600(24)00191-7

No abstract available

MeSH terms

Antineoplastic Agents / therapeutic use
Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Lung Neoplasms* / drug therapy
Microtubules / drug effects
Tubulin Modulators / therapeutic use

Substances

Tubulin Modulators
Antineoplastic Agents